Stock Evaluator: Vogenx, Inc. (VOGX)

Vogenx, Inc. VOGX

$12.84 -0.65 -4.78%
November 18, 2026 1:45:16 PM EST November 10, 2021 Volume: 77,546
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Pharmaceuticals

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party payors in the United States. The company was incorporated in 2021 and is based in Raleigh, North Carolina.

Commentary & Analysis


Financial Summary

Share Statistics VOGX Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $199.9 $436.9 29%
Shares Out (Mil) 5.5 46.5 15%
Institutional Ownership 40.3% 82.2% 16%
Float (Mil) 8.1 47.7 17%
Beta na 0.68 na
Avg Daily Volume (000s) 122 339 38%
Price Change
(52-week)
na 52.1% na
Growth VOGX Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 6.6% na
Net Income (5yr) na (1.6%) na
EPS (5yr) na 15.1% na
Dividends (5yr) na 0.0% na
Cash Flow (5yr) na (15.1%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials VOGX Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) na $289 na
Net Income (TTM) (Mil) ($2) ($11) 36%
EPS (TTM) ($0.303) ($0.600) 30%
Operating Cash Flow (TTM) (Mil) ($1) ($7) 30%
Net Cash Flow (TTM) (Mil) na $1 na
Long-Term Debt (Q1) (Mil) $0 $6 0%
Enterprise Value (Q1) (Mil) $484 $331 34%
Valuation VOGX Industry
Median
Percentile
(All Stocks)
P/B na 2.15 na
P/E na 24.2 na
Dividend Yield na 0.0% na
PEG (5yr hist) na 1.2 na
Ratios VOGX Industry
Median
Percentile
(All Stocks)
Gross Margin na 69.5% na
Net Margin na 3.6% na
ROA (234.8%) (23.3%) 1%
ROE 185.9% (24.7%) 98%
Liabilities to Assets 226.3% 31.8% 99%
F-Score 1 3 na

Vogenx, Inc. did not pass any screens on 11/17/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors